# A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

> **NCT02975102** · NA · COMPLETED · sponsor: **Laboratoire Chauvin** · enrollment: 87 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DEVICE:** CBL-101 Eye Drops
- **DEVICE:** Vismed® Multi Eye Drops

## Key facts

- **NCT ID:** NCT02975102
- **Lead sponsor:** Laboratoire Chauvin
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-09-17
- **Final completion:** 2019-09-17
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975102, "A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02975102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
